Home > Financial Ratios > AJANTA PHARMA

AJANTA PHARMA
EV/Core EBITDA

    Back to All Ratios
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 22.4224.0322.3216.8914.58

What is the latest EV/Core EBITDA ratio of AJANTA PHARMA ?

The latest EV/Core EBITDA ratio of AJANTA PHARMA is 22.42 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202622.42
Mar202524.03
Mar202422.32
Mar202316.89
Mar202214.58

How is EV/Core EBITDA of AJANTA PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2026 22.42
-6.70
Mar2025 24.03
7.66
Mar2024 22.32
32.15
Mar2023 16.89
15.84
Mar2022 14.58 -

Other Financial Ratios of AJANTA PHARMA


Compare EV/Core EBITDA ratio of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹44,475.0 Cr -0.2% -0% 38.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,276.0 Cr -0.3% -3.1% 12.8% Stock Analytics
DIVIS LABORATORIES ₹251,531.0 Cr -1.3% 2.2% 57.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,957.0 Cr -1.3% -2.4% 33.3% Stock Analytics
CIPLA ₹111,729.0 Cr 0.2% -2.5% -9.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,335.0 Cr 3.3% 6.1% -6.5% Stock Analytics


AJANTA PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

-0.2%

-0%

38.9%

SENSEX

-2.7%

-5.7%

-11.7%


You may also like the below Video Courses